The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

43 of 44 Patients Achieved Sustained Virologic Response (SVR)

Back to News Homepage

Next

New Herbal Compound Inhibits the Hepatitis C Virus

Free Hepatitis C Webinar: Treatment Options and the Patient Experience

May 14, 2014

Print this page

In recognition of May being Hepatitis Awareness Month, the American Liver Foundation invites you to participate in a live webinar program, Hepatitis C: Treatment Options and the Patient Experience, on Wednesday, May 28.

Did you know that there are new treatments available for Hep C that require shorter treatment times, have less serious side effects and higher cure rates? Learn about the changing landscape of treatment options and how they affect the patient experience. Our program features a physician and nurse practitioner who specialize in liver disease and two patient advocates who share their experience of living with Hep C. All four panelists will be available for a live question and answer session following the presentation.

The four panelists include:

Priya Grewal, MD
Associate Professor of Medicine
Icahn School of Medicine at Mount Sinai
Recanati/Miller Transplantation Institute
Mount Sinai Medical Center

Kathryn Jack, MSN, FNP-BC, APRN
Connecticut GI, PC
Midstate Medical Center
Meriden, CT

David Roncari
Hep C Patient Advocate
Connecticut

Maria Alvarez
Hep C Patient Advocate
Connecticut

To register for the 12:00pm ET webinar, click here to get started: https://attendee.gotowebinar.com/register/1568476785014980866

To register for the 3:00pm ET webinar, click here to get started: https://attendee.gotowebinar.com/register/9156175741972001026

No Comments - be the first!
Share
Share

Previous

43 of 44 Patients Achieved Sustained Virologic Response (SVR)

Back to News Homepage

Next

New Herbal Compound Inhibits the Hepatitis C Virus

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.